Articles dans des revues avec comité de lecture (183)
  1. 86. Boutajangout, A., Boom, A., Leroy, K., & Brion, J. P. (2004). Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. FEBS letters, 576(1-2), 183-189. doi:10.1016/j.febslet.2004.09.011
  2. 87. Boom, A., Pochet, R., Authelet, M., Pradier, L., Borghgraef, P., Van Leuven, F., Heizmann, C. W., & Brion, J. P. (2004). Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochimica et biophysica acta, 1742(1-3), 161-168. doi:10.1016/j.bbamcr.2004.09.011
  3. 88. Leroy, K., Boutajangout, A., Richardson, J. C., Octave, J. N., Lovestone, S., Anderton, B., & Brion, J. P. (2003). Mutant presenilin 1 proteins induce cell death and reduce tau-dependent processes outgrowth. Neuroscience letters, 353(3), 226-230. doi:10.1016/j.neulet.2003.09.051
  4. 89. Hanger, D., Gibb, G. M., de Silva, R., Boutajangout, A., Brion, J. P., Revesz, T., Lees, A. J., & Anderton, B. (2002). The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS letters, 531(3), 538-542. doi:10.1016/S0014-5793(02)03611-6
  5. 90. Leroy, K., Boutajangout, A., Authelet, M., Woodgett, J. R., Anderton, B., & Brion, J. P. (2002). The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathologica, 103(2), 91-99. doi:10.1007/s004010100435
  6. 91. Boutajangout, A., Leroy, K., Touchet, N., Authelet, M., Blanchard, V., Tremp, G., Pradier, L., & Brion, J. P. (2002). Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. Neuroscience letters, 318(1), 29-33. doi:10.1016/S0304-3940(01)02461-2
  7. 92. Killick, R., Pollard, C. C., Asuni, A. A., Mudher, A. K., Richardson, J. C., Rupniak, H. T., Sheppard, P. W., Varndell, I. M., Brion, J. P., Levey, A. I., Levy, O. A., Vestling, M., Cowburn, R., Lovestone, S., & Anderton, B. (2001). Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. The Journal of biological chemistry, 276(51), 48554-48561. doi:10.1074/jbc.M108332200
  8. 93. Leroy, K., Duyckaerts, C., Bovekamp, L., Müller, O., Anderton, B., & Brion, J. P. (2001). Increase of adenomatous polyposis coli immunoreactivity is a marker of reactive astrocytes in Alzheimer's disease and in other pathological conditions. Acta Neuropathologica, 102(1), 1-10.
  9. 94. Brion, J. P., Anderton, B., Authelet, M., Dayanandan, R., Leroy, K., Lovestone, S., Octave, J. N., Pradier, L., Touchet, N., & Tremp, G. (2001). Neurofibrillary tangles and tau phosphorylation. Biochemical Society Symposia,(67), 81-88.
  10. 95. Anderton, B., Betts, J., Blackstock, W. P., Brion, J. P., Chapman, S. J., Connell, J., Dayanandan, R., Gallo, J. M., Gibb, G. M., Hanger, D., Hutton, M., Kardalinou, E., Leroy, K., Lovestone, S., Mack, T. G., Reynolds, C. H., & Van Slegtenhorst, M. (2001). Sites of phosphorylation in tau and factors affecting their regulation. Biochemical Society Symposia,(67), 73-80.
  11. 96. Toussaint, O., Baret, P. V., Brion, J. P., Cras, P., Collette, F., De Deyn, P. P., Geenen, V., Kienlen-Campard, P. K., Labeur, C., Legros, J. J., Neve, J., Octave, J. N., Piérard, G. E., Salmon, E., van den Bosch de Aguilar P, P., Van der Linden, M., Leuven, F. V., & Vanfleteren, J. (2000). Experimental gerontology in Belgium: from model organisms to age-related pathologies. Experimental gerontology, 35(8), 901-916.
  12. 97. Brion, J. P. (2000). Neuropathologie de la substance blanche. Radiologie, 20(5), 203-208.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Suivant >>